Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 100 clinical trials
Featured trial
Integument-2 study

We are currently recruiting pediatric and adult patients with mild to moderate atopic dermatitis (eczema) for a study that investigates the safety and efficacy of the ARQ-151 cream.

  • 68 views
  • 07 Jul, 2022
  • 63 locations
Featured trial
Integument-1 study

We are currently recruiting pediatric and adult patients with mild to moderate atopic dermatitis (eczema) for a study that investigates the safety and efficacy of the ARQ-151 cream. 

  • 34 views
  • 15 Aug, 2022
  • 55 locations
Featured trial
Integument-PED study

We are currently recruiting pediatric and adult patients with mild to moderate atopic dermatitis (eczema) for a study that investigates the safety and efficacy of the ARQ-151 cream. 

  • 53 views
  • 17 Aug, 2022
  • 89 locations
Featured trial
A research study for people with moderate to severe atopic dermatitis.

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous Lirentelimab in Adult Subjects with Moderate-to-Severe Atopic Dermatitis Inadequately Controlled by Topical Treatments

topical corticosteroid
crisaborole
corticosteroids
topical agents
  • 0 views
  • 11 Jul, 2022
  • 1 location
Featured trial
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, and Pharmacokinetic Profile of ANB020 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis

This is a 24-week randomized, double blind, placebo controlled, parallel group, dose ranging, Phase 2b study designed to assess the efficacy of different doses and dose regimens of Etokimab compared to placebo in adult subjects with moderate to severe atopic dermatitis (AD). This study will also assess the safety, tolerability, …

  • 61 views
  • 23 Nov, 2020
  • 1 location
Featured trial
We are currently recruiting participants for the BLUEPRINT study. This study investigates the effectiveness, safety, and tolerability of the drug BLU-5937 for chronic itch in people with eczema.

The BLUEPRINT study consists of taking two tablets orally, twice a day, for a period of 4 weeks. This treatment is experimental. You will have 50% chance to receive BLU-5937 and 50% chance to receive the placebo. There will be a total of 5 visits at the clinic and 2 …

eczema
dermatitis
atopic dermatitis
atopic dermatitis/eczema
adult atopic dermatitis
  • 82 views
  • 10 Dec, 2020
  • 25 locations
Featured trial
INCB 18424-303: Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE-AD1)

A Phase 3, randomized (2:2:1), double-blind, 8-week vehicle control efficacy and safety study of ruxolitinib followed by a randomized, double-blind, 44-week long term safety (LTS) extension period.  In the LTS period,  participants initially randomized to vehicle will receive either ruxolitinib 0.75% or 1.5% cream.  All participants will have follow-up assessments …

atopic dermatitis
atopic dermatitis/eczema
eczema
  • 582 views
  • 10 May, 2022
  • 19 locations
Featured trial
INCB 18424-304: Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 2 (TRuE-AD2) for 304

A Phase 3, randomized (2:2:1), double-blind, 8-week vehicle control efficacy and safety study of ruxolitinib followed by a randomized, double-blind, 44-week long term safety (LTS) extension period.  In the LTS period,  participants initially randomized to vehicle will receive either ruxolitinib 0.75% or 1.5% cream.  All participants will have follow-up assessments …

atopic dermatitis
atopic dermatitis/eczema
eczema
dermatitis
  • 423 views
  • 03 May, 2022
  • 11 locations
Featured trial
A 3-week study to evaluate a generic non-steroidal topical cream for the treatment of eczema.

A 3-week study to evaluate a generic non-steroidal topical cream for the treatment of eczema.

  • 190 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A 4-week study to evaluate a generic non-steroidal topical cream for the treatment of eczema.

A 4-week study to evaluate a generic non-steroidal topical cream for the treatment of eczema.

  • 109 views
  • 08 Nov, 2020
  • 1 location